MedPath

To give tranexamic acid in reducing postpartum blood loss in vaginal deliveries

Phase 2
Registration Number
CTRI/2024/04/066348
Lead Sponsor
DR SN MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

prmigravida or secondary gravida

37 to 42 weeks of gestation

admitted in active labour

normotensive

cephalic presentation

Exclusion Criteria

All other patients not fulfilling the inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To quantify the mean 2hour postpartum blood lossTimepoint: from delivery to 2 hour postpartum
Secondary Outcome Measures
NameTimeMethod
To see if any other intervention needed after delivery & to compare the need of blood transfusion & to see the potential adverse effects of tranexamic acid. <br/ ><br>Timepoint: from delivery till patient discharged.
© Copyright 2025. All Rights Reserved by MedPath